Using the Rapid Heme Panel for accurate blood cancer diagnoses | Dana-Farber Cancer Institute
813 views · Published 13 March 2017 · 1:33 · Indexed 18 October 2026
Channel: Dana-Farber Cancer Institute · 2017 · Science & Technology
The Rapid Heme Panel is a diagnostic test for leukemia and MDS developed by scientists at Dana-Farber Cancer Institute and Brigham and Women’s Hospital. It identifies the genetic mutations in a patient’s blood cancer. Robert Soiffer, MD, Chief of the Division of Hematologic Malignancies at Dana-Farber explains how the Rapid Heme Panel helps his team achieve an accurate diagnosis and then tailor treatment based on a patient’s specific mutations. Read a case study showcasing the Rapid Heme Panel in practice.
More from this channel
-
0:18
Importance of Joining the Stem Cell Registry | Dana-Farber Cancer Institute
-
0:20
How to Join the Stem Cell Registry | Dana-Farber Cancer Institute
-
0:18
How to Register as a Stem Cell Donor | Dana-Farber Cancer Institute
-
3:03
Sportscaster Jim Britt for the Jimmy Fund | Dana-Farber Cancer Institute
-
0:07
Dana-Farber Banners | Dana-Farber Cancer Institute
-
2:08
Barbers for the Jimmy Fund | Dana-Farber Cancer Institute
-
1:43
Pets | Dana-Farber Cancer Institute
-
1:34
Healthy Eating for the Holiday Season | Dana-Farber Cancer Institute